AUS
NZ
UK
CA
USA
IND
Healthcare
Tariff Pressures Forecast to Increase Costs for Fisher & Paykel (ASX:FPH) in FY26
February 03, 2025 11:15 AM AEDT| By Team Kalkine MediaHighlights,Tariffs imposed on Mexico are,anticipated,to elevate manufacturing costs in FY26.,Approximately 50% of manufacturing occurs in Mexico and 50% in New Zealand, with 43% of first-half FY25 revenues generated from the U.S.,While FY25 net profi...
Innovative GI Imaging Trial in Germany Paves the Way for Next-Generation Endomicroscopy (ASX:OIL)
February 03, 2025 11:13 AM AEDT| By Team Kalkine MediaHighlights,Pre-Clinical Initiative:,A pre-clinical study has been launched at the University Medical Centre of the Johannes Gutenberg University in Mainz to assess Gen2 real-time imaging technology on gastrointestinal (GI) tract tissue.,Collaborative...
Is Paradigm Biopharmaceuticals Making Progress with its Osteoarthritis Treatment Development?
February 01, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Paradigm Biopharmaceuticals (ASX:PAR) partners with Advanced Clinical for the PARA_OA_012 phase III osteoarthritis trial.,Advanced Clinical brings a strong track record in clinical trials, patient engagement, and regulatory strategy.,The...
Is the Biotech Sector on the Verge of a Major Breakthrough?
February 01, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Emyria's MDMA Trial Shows Lasting PTSD Relief,: Emyria (ASX:EMD) reports its MDMA-based therapy continues demonstrating notable improvements in PTSD symptoms, even months after treatment.,Argenica's Breakthrough in Traumatic Brain Injury...
Are Biotech Companies Facing Unforeseen Hurdles?
February 01, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Percheron Therapeutics (ASX:PER) discontinues its lead candidate following a DMD trial setback.,Immutep (ASX:IMM) continues multiple clinical programs amid valuation challenges.,Impedimed (ASX:IPD) and Micro-X (ASX:MX1) secure funds to sup...
Is the Health Sciences Sector Experiencing Significant Change?
February 01, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Sigma Healthcare (ASX:SIG) to combine operations with Chemist Warehouse in a major industry realignment.,Biome Australia (ASX:BIO) secures funding from the Food and Beverage Accelerator for its innovative probiotic strain research.,Cynata...
Is This Quiet Stock About to Shake Up the Market?
January 31, 2025 03:31 PM AEDT| By Team Kalkine MediaHighlights:,Alterity Therapeutics' stock surged by 260% in the past year.,Recent capital raise strengthens the company's financial position.,Investors should stay informed about possible risks linked to its outlook.,Alterity Therapeutics (ASX:ATH), a...
Prescient Therapeutics Gears Up for Transformative Year with New Leadership and Key FDA Clearance
January 31, 2025 01:38 PM AEDT| By Team Kalkine MediaHighlights:,New CEO James McDonnell,appointed,and FDA clearance received for PTX-100 Phase 2 clinical trial.,Successful IND application for PTX-100 Phase 2 trial in r/,rCTCL,, with immediate initiation.,Significant progress,in,CellPryme,and,OmniCAR,d...
Race Oncology (ASX:RAC) Advances RC220 Phase 1 Trial and Strengthens Leadership Team
January 31, 2025 12:12 PM AEDT| By Team Kalkine MediaHighlights,RC220 Phase 1 Trial Progress,:,Ethics and regulatory submissions completed, with first patient treatment,anticipated,in Q1 CY2025.,Leadership Expansion,:,Appointment of Dr Megan Baldwin as an independent non-executive director, along with...
Mesoblast (ASX:MSB) Advances Ryoncil Launch Following FDA Approval
January 31, 2025 11:12 AM AEDT| By Team Kalkine MediaHighlights:,Mesoblast (,ASX:MSB,) secures $260 million funding,for the commercial launch of,Ryoncil,in the US.,Ryoncil,gains FDA approval,, leading to a 54% surge in Mesoblast shares on December 19.,Ryoncil,targets,pediatric,complications,arising fro...
ResMed Shares Surge on Q2 Earnings Report, Revenue Jumps 10%
January 31, 2025 11:11 AM AEDT| By Team Kalkine MediaHighlights,Revenue Growth:,ResMed posted a 10% year-over-year revenue increase to,$1.3 billion,, exceeding market expectations.,Profit Surge:,Operating income jumped,52%,to,$417.2 million,, while non-GAAP net income rose,29%,to,$358.3 million,.,Posit...
How Are Paradigm Biopharmaceuticals' Strategic Initiatives Shaping Its Future?
January 31, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Paradigm Biopharmaceuticals introduces a loyalty and piggyback options offer, aimed at raising over $110 million.,Shareholders can benefit from additional shares through the company's loyalty options program.,The company prepares to launc...
What’s Driving the Surge in ASX Health Stocks?
January 31, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,The S&P/ASX 200 Health Care Index rose by 3.3% last week, outperforming the general market's 1.9% increase.,Microba’s quarterly sales surged, while Mach7 Technologies initiated a $5 million share buyback.,Aroa Biosurgery faced a setback fo...
Steady Growth at Medical Developments International Limited (ASX:MVP) Supports Its Share Price
January 31, 2025 09:31 AM AEDT| By Team Kalkine MediaUnderstanding Medical Developments International's Current Valuation
Explore ASX Penny Stocks Highlighting Mayne Pharma Group and Two More
January 30, 2025 11:30 PM AEDT| By Team Kalkine MediaExploring ASX Penny Stocks Amid Market Dynamics
EZZ Life Science (ASX:EZZ) Lags, But Strong Financials Signal Potential
January 30, 2025 01:32 PM AEDT| By Team Kalkine MediaEZZ Life Science Holdings Limited (ASX:EZZ) Stock Has Been Underperforming Recently, Yet Financials Show Strength: Is It a Good Opportunity for Potential Shareholders?
ASX Quarterly Health Update: Bioxyne Sees 77% Revenue Increase, Radiopharm Debuts on Nasdaq
January 30, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Bioxyne (ASX:BXN) achieves significant revenue growth with expanded product offerings.,Radiopharm Theranostics (ASX:RAD) makes progress with cancer therapies and strengthens US presence.,Tryptamine Therapeutics (ASX:TYP) advances in clini...
AdAlta strengthens leadership in the second quarter of fiscal year 2025 to enhance growth strategy.
January 30, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,AdAlta expands leadership team with new board members and advisors to enhance growth plans.,First non-binding term sheet signed for East to West cellular therapy strategy in China.,Ongoing momentum in cellular immunotherapy and fibrosis tr...
Why Is This Low-Key Stock Suddenly Making Waves?
January 30, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Blinklab Initiates FDA Study:,Blinklab (ASX:BB1) has launched an FDA registrational study for its Dx 1 platform, aimed at improving autism diagnosis, with final results expected by the end of CY25.,Mach7 Technologies Reports Growth:,Mach7...
Bio-Gene Secures U.S. Defence Contracts for Innovative Insecticides, Shares Up 130%
January 29, 2025 01:33 PM AEDT| By Team Kalkine MediaHighlights,Major U.S. Defence Grants:,Bio-Gene Technology receives $3 million in contracts to develop its flagship insecticides.,Wearable Insecticide:,A $1.6 million grant will fund the development of Flavocide as a wearable product.,Bed Bug Solution...
Advertise your brand on Kalkine Media